BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26841866)

  • 1. Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.
    Varier RA; Carrillo de Santa Pau E; van der Groep P; Lindeboom RG; Matarese F; Mensinga A; Smits AH; Edupuganti RR; Baltissen MP; Jansen PW; Ter Hoeve N; van Weely DR; Poser I; van Diest PJ; Stunnenberg HG; Vermeulen M
    J Biol Chem; 2016 Apr; 291(14):7313-24. PubMed ID: 26841866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation.
    Garapaty S; Xu CF; Trojer P; Mahajan MA; Neubert TA; Samuels HH
    J Biol Chem; 2009 Mar; 284(12):7542-52. PubMed ID: 19131338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase (NuRD) complex.
    Nishibuchi G; Shibata Y; Hayakawa T; Hayakawa N; Ohtani Y; Sinmyozu K; Tagami H; Nakayama J
    J Biol Chem; 2014 Oct; 289(42):28956-70. PubMed ID: 25190814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
    Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
    Mol Cell; 2014 Mar; 53(5):806-18. PubMed ID: 24582497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of EMSY gene in sporadic ovarian cancer.
    Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
    Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase KDM5A is transactivated by the transcription factor C/EBPβ and promotes preadipocyte differentiation by inhibiting Wnt/β-catenin signaling.
    Guo L; Guo YY; Li BY; Peng WQ; Tang QQ
    J Biol Chem; 2019 Jun; 294(24):9642-9654. PubMed ID: 31061100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM5 lysine demethylases are involved in maintenance of 3'UTR length.
    Blair LP; Liu Z; Labitigan RL; Wu L; Zheng D; Xia Z; Pearson EL; Nazeer FI; Cao J; Lang SM; Rines RJ; Mackintosh SG; Moore CL; Li W; Tian B; Tackett AJ; Yan Q
    Sci Adv; 2016 Nov; 2(11):e1501662. PubMed ID: 28138513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
    Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
    Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.
    Vicent GP; Nacht AS; Font-Mateu J; Castellano G; Gaveglia L; Ballaré C; Beato M
    Genes Dev; 2011 Apr; 25(8):845-62. PubMed ID: 21447625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas.
    Madjd Z; Akbari ME; Zarnani AH; Khayamzadeh M; Kalantari E; Mojtabavi N
    Asian Pac J Cancer Prev; 2014; 15(4):1783-9. PubMed ID: 24641409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
    Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
    Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.
    Beshiri ML; Holmes KB; Richter WF; Hess S; Islam AB; Yan Q; Plante L; Litovchick L; Gévry N; Lopez-Bigas N; Kaelin WG; Benevolenskaya EV
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18499-504. PubMed ID: 23093672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
    Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
    Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.
    Jelinic P; Eccles LA; Tseng J; Cybulska P; Wielgos M; Powell SN; Levine DA
    Oncotarget; 2017 Feb; 8(8):13792-13804. PubMed ID: 28099152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations of CCND1 and EMSY in breast cancers.
    Kirkegaard T; Nielsen KV; Jensen LB; Campbell FM; Müller S; Tovey SM; Brown S; Cooke TG; Bartlett JM
    Histopathology; 2008 May; 52(6):698-705. PubMed ID: 18393977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
    Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.
    Ezell SA; Polytarchou C; Hatziapostolou M; Guo A; Sanidas I; Bihani T; Comb MJ; Sourvinos G; Tsichlis PN
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):E613-21. PubMed ID: 22315412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.